Description of the image
Description of the image


Fundamentals and Regulatory

(Chair: Thomas Kreil Ph.D., Associate Professor of Virology, Vice President, Global Pathogen Safety, Takeda)


New chapter in the European Pharmacopeia on high-throughput sequencing for the detection of viral extraneous agents

Johannes Bluemel, Ph.D.

Head of Viral Safety Section, Infectiology, Paul-Ehrlich-Institute


Enhancing Viral Safety: Prior knowledge and platform virus clearance strategies in the era of ICHQ5A (R2)

Andy Bailey, Ph.D.

CEO, ViruSure GmbH


Implications of the ICHQ5A (R2) on viral clearance studies scopes

Anja Tessarz, Ph.D.

Associate Director R&D, SME Viral Clearance, Charles River Laboratories Germany GmbH


Nanofiltration of challenging plasma derived proteins

(Chair: Elisa Moretti, PhD., Senior Director Global Pathogen Safety/Global Manufacturing Science & Development (GMSD), Kedrion Biopharma)

 

Robustness study of Planova S20N (TBC)

Changes in nanofilters: case studies for switching to state-of-the-art nanofilters in established and developing manufacturing processes

Martyn Paddick, Ph.D.

Director Global Process Development & Industrialization, Kedrion Biopharma


Mechanistic Insights into Virus Filtration Process by Direct Visualization of Retention Profiles

Remo Leisi, Ph.D.

Head of Breakthrough Technologies & Technical Innovation, CSL


Rapid nanofiltration enabling highly efficient processing

(Chair: Uwe Gottschalk, PhD., Operating Partner, Keensight Capital former Lonza CSO)

 

Evaluation of Planova FG1 Virus Filter: Enhancing Efficiency and Addressing Filterability Challenges in a Diverse Therapeutic Antibody Pipeline

Ludivine Profit

Scientist, Purification Process Development, Sanofi


Evaluation of Planova S20N on a challenging mAb solution prone to aggregation (TBC) 

Evaluation of Planova FG1 (TBC)


Cell Culture Clarification with Tangential Flow Microfiltration

(Chair: Ashley Baltes, Scientific Director, Just-Evotec Biologics, Inc)

 

Cell Culture Clarification with Tangential Flow Microfiltration in a perfusion production (TBC) 

Intensification Strategies for Adeno Associated Virus Production Processes

Thomas Villiger, PhD.

Professor of Bioprocess Technology, University of Applied Sciences and Arts Northwestern Switzerland

FHNW


Optimizing TFF Hollow Fiber Filtration for Scalable Perfusion Bioprocessing

Patrick Romann, Ph.D.

Bioprocess Innovation Manager, R&D, Levitronix


New Trends and Applications

(Chair: Alex Harley, SME – Viral Clearance, Downstream Process Development, FUJIFILM Biotechnologies)

 

Media nanofiltration for Advanced Therapy Medicinal Products (ATMP) (TBC)

Exploring the Approach for rAAV Downstream Early-Stage Viral Clearance Study

Yu-Tsan (Richard) Liu

Senior Scientist, Gene Therapy Process Sciences Downstream, UCB Pharma SA 


Evaluation of Viral Filter Performance in an End-to-End Continuous Process

Jodi Chen

Scientist, Purification, PD, Just-Evotec Biologics

 

Poster Session


Study of Superior Microfiltration Membrane Structure for Perfusion Cell Culture: Influence of Cell Density and Shear at Membrane Surface on Filtration Performance

Shun Matsuda, Scientist, Research and Technology Development Div., Asahi Kasei Life Science Co., Ltd.


Non-Pressurized Membrane Concentration for Pharmaceutical Manufacturing: Forward Osmosis and Membrane Distillation

Junji Sakuda, Ph.D.

Manager, Corporate Research & Development., Asahi Kasei Corporation


The features of membrane structure and production method of BioOptimal UMP

and MFSL filters

Yuki Miki

Chief Researcher, Microza Research & Development Department., Asahi Kasei Corporation


Hybrid PCR-Based Mycoplasma Detection for Product-Specific Suitability and USP<63> Comparability for High Cell Density Products

Lori Daane, PhD

Chief Scientific Officer, Bionique Testing Laboratories LLC


A comparison of Planova FG1 virus filter performance and product quality on various modalities of biologics

Minni Aswath

Vice President, Process Development., Bionova Scientific LLC


GMP Implementation of Oxford Nanopore’s long-read sequencing technology for

the detection of adventitious viruses in biopharmaceutical products

Hans-Peter Fasching

Deputy Head of Molecular Biology Department, ViruSure GmbH




    

                           GET IN TOUCH: 

             

© Copyright 2025 Asahi Kasei